251 related articles for article (PubMed ID: 21546603)
1. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.
Ndumele CE; Nasir K; Conceiçao RD; Carvalho JA; Blumenthal RS; Santos RD
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1927-32. PubMed ID: 21546603
[TBL] [Abstract][Full Text] [Related]
2. Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.
Keenan T; Blaha MJ; Nasir K; Silverman MG; Tota-Maharaj R; Carvalho JA; Conceição RD; Blumenthal RS; Santos RD
Am J Cardiol; 2012 Dec; 110(12):1787-92. PubMed ID: 22975466
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Huţanaşu IC; Ungureanu D; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):692-9. PubMed ID: 23272512
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between inflammation, C-reactive protein, and insulin resistance.
Ndumele CE; Pradhan AD; Ridker PM
J Cardiometab Syndr; 2006; 1(3):190-6. PubMed ID: 17679826
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis.
den Engelsen C; Koekkoek PS; Gorter KJ; van den Donk M; Salomé PL; Rutten GE
Cardiovasc Diabetol; 2012 Mar; 11():25. PubMed ID: 22417460
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
Riquelme A; Arrese M; Soza A; Morales A; Baudrand R; Pérez-Ayuso RM; González R; Alvarez M; Hernández V; García-Zattera MJ; Otarola F; Medina B; Rigotti A; Miquel JF; Marshall G; Nervi F
Liver Int; 2009 Jan; 29(1):82-8. PubMed ID: 18647235
[TBL] [Abstract][Full Text] [Related]
10. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population.
Shaharyar S; Roberson LL; Jamal O; Younus A; Blaha MJ; Ali SS; Zide K; Agatston AA; Blumenthal RS; Conceição RD; Santos RD; Nasir K
J Obes; 2015; 2015():178526. PubMed ID: 25838943
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.
Carallo C; Mancuso G; Mauro G; Laghi F; Madafferi B; Irace C; Gnasso A; Scavelli F; Dell'Aquila F; Bartone M; Gullo F; Ferraro M; Spagnuolo V; Belmonte M; Ferrara A; Silvano Rotondaro A; Brandolino N; Parasporo F; Scopelliti F
J Gastroenterol; 2009; 44(11):1156-61. PubMed ID: 19802520
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.
Yeniova AO; Küçükazman M; Ata N; Dal K; Kefeli A; Başyiğit S; Aktaş B; Ağladioğlu K; Akin KO; Ertugrul DT; Nazligül Y; Beyan E
Hepatogastroenterology; 2014; 61(130):422-5. PubMed ID: 24901154
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of adipokines and indices of metabolic syndrome as predictors of severe obesity-related hepatic steatosis.
Méndez-Sánchez N; Chávez-Tapia NC; Medina-Santillán R; Villa AR; Sánchez-Lara K; Ponciano-Rodríguez G; Ramos MH; Uribe M
Dig Dis Sci; 2006 Oct; 51(10):1716-22. PubMed ID: 17203555
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males.
Lim SY; Rhee EJ; Sung KC
J Korean Med Sci; 2010 Oct; 25(10):1480-6. PubMed ID: 20890430
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths.
Kelishadi R; Cook SR; Amra B; Adibi A
Atherosclerosis; 2009 Jun; 204(2):538-43. PubMed ID: 19013572
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis C.
Hayman AV; Sofair AN; Manos MM; Thomas A; Terrault N; Ness GV; Stabach N; Robert M; Rumore G; Corless C; Bell B; Bialek S; Zaman A
Medicine (Baltimore); 2009 Sep; 88(5):302-306. PubMed ID: 19745689
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
[TBL] [Abstract][Full Text] [Related]
18. Relation of hepatic steatosis to atherogenic dyslipidemia.
Makadia SS; Blaha M; Keenan T; Ndumele C; Jones S; DeFilippis A; Martin S; Kohli P; Conceicao R; Carvalho J; Nasir K; Blumenthal R; Santos RD
Am J Cardiol; 2013 Nov; 112(10):1599-604. PubMed ID: 24012029
[TBL] [Abstract][Full Text] [Related]
19. Elevated High Sensitivity C-Reactive Protein Increases the Risk of Microalbuminuria in Subjects With Cardiovascular Disease Risk Factors.
Yang SK; Liu J; Yi B; Mao J; Zhang XM; Liu Y; Lei DD; Gui M; Zhang H
Ther Apher Dial; 2017 Aug; 21(4):387-394. PubMed ID: 28322017
[TBL] [Abstract][Full Text] [Related]
20. Fatty liver and abdominal fat relationships with high C-reactive protein in adults without coronary heart disease.
Cardoso-Saldaña GC; Medina-Urrutia AX; Posadas-Romero C; Juárez-Rojas JG; Jorge-Galarza E; Vargas-Alarcón G; Posadas-Sánchez R
Ann Hepatol; 2015; 14(5):658-65. PubMed ID: 26256894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
